Reductions in Healthcare Resource Utilization Among Patients with Hereditary Angioedema with C1-Inhibitor Deficiency Following the Initiation of Berotralstat

Orladeyo (berotralstat) - BioCryst Pharmaceuticals

https://events.rdmobile.com/Lists/Details/3220804

Sandra Christiansen MD 1; Tracy Yee 2; Francois Laliberte 3; Patrick Gravelle 3; Sandra Nestler-Parr 2; Patrick Gillard 4; Bruce Zuraw MD 5

Feb 10, 2026